European Archives - Page 119 of 1110 - European Medical Journal

AI-Powered ECG Tool Predicts Hypertension and Adverse Events

AI-enhanced ECG predicts hypertension and identifies patients at risk for adverse events, transforming preventive care approaches.

Role of Empagliflozin in Weight Reduction for Diabetic Patients

New research shows impact of blood glucose-lowering medication on patients with diabetes.

Do Cancer-Associated Fibroblasts Help or Hinder Tumour Immunity?

New research reveals the dual role of cancer-associated fibroblasts in tumour immunity, offering insights for future cancer therapies.

Ahmad Awada

Onc Now: Episode 8: New Frontiers in Oncology and Drug Development

Ahmad Awada, Head of the Oncology Department at Chirec Cancer Institute discusses groundbreaking developments in cancer care.

Handshake on blue background

Vertex strikes deal for Orna Therapeutics' LNP technology

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and beta-thalassemia.

Laser-Textured Stents Reduce Restenosis and Boost Vascular Healing

Laser-patterned stent surfaces enhance vascular recovery, doubling angiogenesis while reducing restenosis risk by 75%, study finds.

New Evidence Links Air Pollution to Increased Risk of Venous Thromboembolism

Chronic air pollution exposure significantly raises the risk of venous thromboembolism, underscoring its health impacts and clinical relevance.

Could Elevated Skin Sodium Drive Hypertension in Rheumatoid Arthritis?

Elevated skin sodium in rheumatoid arthritis may drive hypertension, shedding light on new mechanisms linking immune activation and blood pressure.

Characteristics of Human Cases of Avian Influenza A(H5N1)

A recent analysis of human cases of the highly pathogenic avian influenza A(H5N1) virus in the USA has provided new insights into the virus’s effects.

Chronic Gut Virus Linked to Alzheimer’s Disease Development

Chronic gut infections from cytomegalovirus may contribute to Alzheimer’s, opening doors to antiviral treatment possibilities.